STOCK TITAN
  1. Home
  2. News
  3. YTEN

Yield10 Bioscience Inc - YTEN STOCK NEWS

Welcome to our dedicated news page for Yield10 Bioscience (Ticker: YTEN), a resource for investors and traders seeking the latest updates and insights on Yield10 Bioscience.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Yield10 Bioscience's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Yield10 Bioscience's position in the market.

News
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
Yield10 Bioscience, Inc. (YTEN) reported financial results for Q4 and full year 2023, focusing on the commercialization of Camelina products for biofuel and omega-3 markets. They granted a global license to Vision Bioenergy for Camelina. Recent regulatory milestones support the commercial ramp-up of engineered Camelina varieties. Financially, the company ended 2023 with $1.1 million in cash and investments, with a net loss of $14.5 million for the year. Yield10 plans to focus on executing the development program for omega-3 Camelina, obtaining regulatory approval, and engaging commercial partners in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-42.11%
Tags
earnings
-
News
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
Rhea-AI Summary
Yield10 Bioscience, Inc. (YTEN) will report Q4 and full year 2023 financial results on April 1, 2024, with a conference call to discuss financials, corporate highlights, and business updates. Interested parties can join the call through various channels and access a replay afterward.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
Rhea-AI Summary
Yield10 Bioscience, Inc. (YTEN) reports that the Canadian Food Inspection Agency determined E3902 Camelina is not a Plant with Novel Trait, allowing increased oil production and lighter seed coat color. The company plans to continue developing and providing improved Camelina varieties. E3902 Camelina has received favorable regulatory determinations in the United States, Argentina, and Chile.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
none
News
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
Rhea-AI Summary
Yield10 Bioscience achieves regulatory milestone for commercial scale production of omega-3 fatty acids in Camelina, potentially revolutionizing the omega-3 market. The company's modified Camelina varieties are now approved for cultivation in the U.S, offering a sustainable alternative to traditional fish oil sources. Yield10 plans to focus on scaling up production for aquafeed and human nutrition markets, collaborating with industry leaders like BioMar Group.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
81.08%
Tags
none
-
News
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
Rhea-AI Summary
Yield10 Bioscience, Inc. (YTEN) reports successful field tests of herbicide-tolerant winter Camelina varieties crucial for biofuel and omega-3 oil markets. The company tested Camelina engineered with tolerance to glufosinate and stacked herbicide traits, showing promising results. Yield10 aims to enable grower adoption of Camelina on large acreage for biofuel and omega-3 oil production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
none
-
News
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
Rhea-AI Summary
Yield10 Bioscience, Inc. grants VISION Bioenergy Oilseeds, LLC a global license for herbicide tolerant Camelina varieties for biofuel production. VISION will pay $3 million for the license and exclusive commercialization rights for three years. Yield10 retains sublicensing rights and continues developing Camelina for omega-3 oil production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
none
News
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
Rhea-AI Summary
Yield10 Bioscience, Inc. (Nasdaq:YTEN) provides an update on its Omega-3 Camelina program, focusing on advancing and commercializing the program. The company has completed contra season production of Omega-3 Camelina seed in Chile and is working on securing a global commercial license. They are also transferring the EPA trait into proprietary Yield10 herbicide tolerant Camelina germplasm to boost in-field agronomics and yield. Yield10 has also provided an update on the status of its Nasdaq listing, awaiting a decision from the Nasdaq Hearings Panel.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.03%
Tags
none
-
News
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
Rhea-AI Summary
Yield10 Bioscience, Inc. (YTEN) has filed a request for a Regulatory Status Review with USDA-APHIS Biotechnology Regulatory Services for proprietary elite Camelina sativa varieties designed to produce omega-3 oil containing both essential fatty acids EPA and DHA, closely resembling the profile of fish oil. The company aims to address the global demand for omega-3 oils in aquafeed and human nutrition markets through land-based production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States
Rhea-AI Summary
Yield10 Bioscience, Inc. (Nasdaq:YTEN) announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s Biotechnology Regulatory Services has approved the growth and breeding of Yield10’s stacked herbicide tolerant Camelina sativa in the United States. This approval allows the development of Camelina varieties with tolerance to specific herbicides, aiming to achieve large-acreage adoption of the crop in North America.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.13%
Tags
none
News
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
Rhea-AI Summary
Yield10 Bioscience (YTEN) achieves a significant milestone in the development of Camelina for biofuels and Omega-3 oils. The USDA-APHIS has cleared glufosinate tolerant Camelina for growth and breeding in the U.S., driving commercial launch as early as 2025. Yield10's approach to developing elite Camelina varieties aims to benefit growers, offering new options for weed management and sustainable agriculture solutions. The company is building seed inventory to support commercial launch and expand its portfolio of commercial Camelina varieties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.13%
Tags
none
Stock YTEN logo
Yield10 Bioscience Inc

Nasdaq:YTEN

YTEN Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

YTEN Stock Data

4.78M
14.21M
12.61%
3.97%
6.11%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
US
Woburn

About YTEN

yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.